Impax Asset Management Group
CHRS icon

Impax Asset Management Group’s Coherus Oncology CHRS Stock Holding History

Impax Asset Management Group’s Portfolio CHRS Stock Details CHRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-365,248
Closed -$5.34M – 405
2021
Q1 		$5.34M Sell
365,248
-309,752
-46% -$5.26M 0.03% 193
2020
Q4 		$11.7M Hold
675,000
– – 0.07% 114
2020
Q3 		$12.4M Buy
675,000
+25,000
+4% +$465K 0.11% 105
2020
Q2 		$11.6M Buy
650,000
+125,000
+24% +$2.12M 0.12% 109
2020
Q1 		$8.52M Hold
525,000
– – 0.11% 111
2019
Q4 		$9.45M Buy
+525,000
New +$9.68M 0.11% 122

Other funds holding CHRS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
ACB
Aristotle Capital Boston Boston, Massachusetts $1.61B AUM 19.82% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Impax Asset Management Group's CHRS Position: Q2 2021 in Review

Impax Asset Management Group sold out of Coherus Oncology (CHRS) in Q2 2021, closing a stake of 365,248 shares — an estimated $5.34M sold.

Impax Asset Management Group first reported a position in CHRS in Q4 2019 and held it in 6 quarters. The position peaked at $12.4M in Q3 2020. 188 funds tracked by Wall St. Rank hold CHRS as of Q2 2021.

  • Impax Asset Management Group reported no remaining Coherus Oncology position as of Q2 2021 after selling out during the quarter.
  • Impax Asset Management Group sold 365,248 Coherus Oncology shares in Q2 2021, an estimated $5.34M.
  • Impax Asset Management Group first reported a position in Coherus Oncology in Q4 2019 and held it in 6 quarters.
  • Impax Asset Management Group's Coherus Oncology position peaked at $12.4M in Q3 2020.
  • 188 funds tracked by Wall St. Rank held Coherus Oncology as of Q2 2021.

Based on Impax Asset Management Group's 13F filing for Q2 2021, filed 5 Aug 2021.